Back
EHRA Premium Access

Characteristics associated with death in patients with atrial fibrillation initiated on rivaroxaban and followed up for 1 year on treatment - an analysis in the pooled XANTUS data

Session: Poster session 3 - Atrial Fibrillation - Stroke Prevention
Topic: Oral Anticoagulation
Speaker: Professor J. Camm (London, GB)
Event: EHRA 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor John Camm

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)
78 presentations
7 followers

8 more presentations in this session

Indexes of anticoagulation control and major adverse outcomes in patients with atrial fibrillation: an analysis from the AFFIRM Trial

Speaker: Associate Professor M. Proietti (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Quality of Anticoagulation Control and Major Adverse Outcomes in European Patients with Atrial Fibrillation: Analysis from EORP-AF General Long-Term Registry

Speaker: Associate Professor M. Proietti (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

The influence of NOAC on sudden neurological death

Speaker: Doctor B. Slavchev (Sofia, BG)

Access
Abstract
Slides
Like
Thumbnail

Ischemic stroke in patient with sinus node disease in comparison to atrial fibrillation, bradycardia-tachycardia syndrome and other cardiac conditions: a nationwide cohort-study

Speaker: Doctor A. Bodin (Tours, FR)

Access
Abstract
Like
Thumbnail

Morpho-functional analysis of the left atrium appendage for stroke risk assessment in atrial fibrillation

Speaker: Doctor C. Tomasi (Ravenna, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 3 - Atrial Fibrillation - Stroke Prevention

Speakers: Professor J. Camm, Associate Professor M. Proietti, Associate Professor M. Proietti, Doctor B. Slavchev, Doctor A. Bodin...
Access
Like
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources